Skip to main content
. Author manuscript; available in PMC: 2022 Oct 1.
Published in final edited form as: Contemp Clin Trials. 2021 Jul 30;109:106519. doi: 10.1016/j.cct.2021.106519

BASELINE SPECIALTY CLINIC CHARACTERISTICS.

Intervention
(N = 26)
Control
(N = 24)
n (%) n (%) p-value a
Site geographic location b Northeast 6 (23.1) 6 (25.0) 0.58 a
Southeast 7 (26.9) 8 (33.3)
Midwest and Northwest 3 (11.5) 5 (20.8)
Southwest and West 10 (38.5) 5 (20.8)
Percent minorities enrolled in previous trials at the site b,c 0%-<10% 7 (26.9) 7 (29.2) 0.63 a
10%-<20% 6 (23.1) 3 (12.5)
≥ 20% 9 (34.6) 11 (45.8)
data N/Ad 4 (15.4) 3 (12.5)
% minorities ≤ 30 miles of siteb,e 17%-<20% 1 (3.8) 1 (4.2) 0.59 a
20%-<40% 14 (53.8) 13 (54.2)
40%-<60% 7 (26.9) 9 (37.5)
60% or more 4 (15.4) 1 (4.2)
% Foreign born ≤ 30 miles of sitee 0%-<10% 7 (26.9) 6 (25.0) 0.60 a
10%-<20% 9 (34.6) 11 (45.8)
20%-<30% 6 (23.1) 2 (8.3)
30% or more 4 (15.4) 5 (20.8)
% Non-English speaking ≤ 30 miles of sitee,f 0%-<10% 7 (26.9) 8 (33.3) 0.89 a
10%-<20% 7 (26.9) 7 (29.2)
20%-<30% 5 (19.2) 3 (12.5)
30% or more 7 (26.9) 6 (25.0)
p-value
Site patients seen per Mean (Standard Deviation) 41.2 (6.3) 78.9 (16.0) 0.10 g
week for any trial c Median 32.5 46
a

P-values from logistic regressions are reported because the analysis had to include parent trial as strata in order to interpret the comparison. Each site contributes one data record.

b

Baseline matching criteria used in randomization

c

Information from investigator demographics form

d

Site not in a previous trial or data not available.

e

Information from US Census

f

Speak a language other than English at home

g

A p-value is reported because the p-value had to be adjusted for clustering within site and stratification by parent trial in order to interpret the comparison